Publication | Open Access

Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial

First-line TherapySurgical OncologyGastrointestinal OncologyAdvanced Gastric CancerMedicineGastroenterologySplit-dose DocetaxelSurgeryCancer TreatmentOncologyRadiation OncologyCancer Research